SCHEMBL4933385

SCHEMBL4933385

Cc1cc(COc2c(Br)cc(CC(F)C(=O)O)cc2Br)cc(NC2CCC2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
THRA P10827 8/20 0.39
THRB P10828 8/20 0.39
POLB P06746 1/20 0.38
DHODH Q02127 2/20 0.34
CNR1 P21554 2/20 0.34
CNR2 P34972 2/20 0.34
ABHD12 Q8N2K0 1/20 0.34
FFAR1 O14842 2/20 0.34
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ABHD6 Q9BV23 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5718054 0.95 MEN1 (0.38) MEN1KMT2ATHRATHRBPOLB
SCHEMBL4930685 0.90 KMT2A (0.37) MEN1KMT2AFFAR1PTGS1PTGS2
SCHEMBL4934402 0.89 THRA (0.38) MEN1KMT2ATHRATHRBDHODH
SCHEMBL5718058 0.87 MEN1 (0.36) MEN1KMT2ATHRATHRBPOLB
SCHEMBL5718015 0.87 MEN1 (0.36) MEN1KMT2ATHRATHRBPOLB
SCHEMBL4932240 0.87 THRA (0.42) THRATHRBDHODH
SCHEMBL4932765 0.85 THRB (0.50) MEN1KMT2ATHRATHRBPOLB
SCHEMBL4934394 0.85 THRB (0.42) MEN1KMT2ATHRATHRBDHODH
SCHEMBL4926936 0.84 THRB (0.43) THRATHRBFFAR1SMN1; SMN2
SCHEMBL4924786 0.84 THRA (0.39) MEN1KMT2ATHRATHRBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA MEN1 773/4885KMT2A 1742/4885THRA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.